Conclusions: Circulating mesothelin is a useful biomarker for pancreatic disease.
结论：对于胰腺疾病，循环中间皮素是一种有效的生物标记物。
This suggests that mesothelin is a potential target for immune-based intervention strategies in pancreatic cancer.
研究显示间皮素可作为胰腺癌患者以免疫治疗为基础的潜在的靶向治疗策略。
We conducted a study on the potential clinical utility of mesothelin as a biomarker for pancreatic disease and therapeutic target pancreatic cancer.
我们研究关于间皮素作为胰腺疾病及胰腺癌靶向治疗的潜在临床应用。
We conducted a study on the potential clinical utility of mesothelin as a biomarker for pancreatic disease and therapeutic target pancreatic cancer.
我们研究关于间皮素作为胰腺疾病及胰腺癌靶向治疗的潜在临床应用。
应用推荐